Orvirem

Russia Acquired By Alvogen
Antiviral syrup for children against influenza and infections is manufactured.

About Orvirem

Orvirem is a Healthcare company based in Russia, and was acquired by Alvogen in June 2015. Antiviral syrup for children against influenza and infections is manufactured. Its focus areas include Pharmaceutical Product Websites.

Company details

Orvirem is based in Russia within the pharmaceutical sector. Syrup-form antiviral medication is produced for children aged one year and older. Treatment and prevention of influenza along with other viral respiratory infections are targeted by this product. Medical professional guidance is required for its use, with potential side effects detailed in accompanying information. Resources on influenza and associated illnesses are supplied by the company. Operations focus on pediatric antiviral solutions.

  • Headquarters Russia
  • Stage Acquired
  • Sectors
    Healthcare
  • Website orvirem.ru
  • Acquired by Alvogen (Jun 2015)
Key Metrics

Investors in Orvirem

Orvirem has secured backing from 1 investor. Prominent investors backing the company include Alvogen.

All
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical products are developed and marketed globally.
2009alvogen.comMontville, United States
Premium access

Investor details for Orvirem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Orvirem

Orvirem is headquartered in Russia.

Orvirem is based in Russia within the pharmaceutical sector. Syrup-form antiviral medication is produced for children aged one year and older. Treatment and prevention of influenza along with other viral respiratory infections are targeted by this product. Medical professional guidance is required for its use, with potential side effects detailed in accompanying information. Resources on influenza and associated illnesses are supplied by the company. Operations focus on pediatric antiviral solutions.

Orvirem has 1 investor. Key investors include Alvogen.

Yes. Orvirem was acquired by Alvogen in June 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available